scholarly journals Apparent Complete Response of a Treatment Refractory and Recurrent Squamous Cell Carcinoma Lesion to Photochemical Internalization: A Clinical Case Study

2020 ◽  
Vol 96 (3) ◽  
pp. 680-683
Author(s):  
Waseem Jerjes ◽  
Zaid Hamdoon ◽  
Kristian Berg ◽  
Anders Høgset ◽  
Colin Hopper
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Clinical Case ◽  
Complete Response ◽  
Clinical Case Study ◽  
Photochemical Internalization ◽  
Recurrent Squamous Cell Carcinoma ◽  
Treatment Refractory ◽  
Carcinoma Lesion

scholarly journals Complete Response of Recurrent Squamous Cell Carcinoma of the Lung: Dose the Dose Matter?

2009 ◽  
Vol 4 (1) ◽  
pp. 141-142
Author(s):  
Sanghoon Shin ◽  
Kwang Joo Kim ◽  
Young Joo Lee ◽  
Hye Jin Choi ◽  
Hyunki Kim ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Complete Response ◽  
Lung Dose ◽  
Recurrent Squamous Cell Carcinoma

The Variable Nature of Stuttering: A Clinical Case Study

1995 ◽  
Vol 22 ◽  
pp. 29-35
Author(s):  
Jennifer Gutierrez ◽  
Anthony Caruso
Keyword(s):  
Clinical Case ◽  
Clinical Case Study ◽  
Variable Nature

Rehabilitation treatment associating maxillary atresia and missing superior incisors – clinical case study report

2017 ◽  
Vol 10 (38) ◽  
pp. 78-83
Author(s):  
João Batista de Paiva ◽  
Daniele Sigal Linhares ◽  
José Rino ◽  
Lindalva Gutierrez
Keyword(s):  
Clinical Case ◽  
Rehabilitation Treatment ◽  
Clinical Case Study ◽  
Study Report ◽  
Case Study Report

scholarly journals Potential implications of Ayurveda in Psoriasis: A clinical case study

2021 ◽  
Author(s):  
Guruprasad C. Nille ◽  
Anand Kumar Chaudhary
Keyword(s):  
Clinical Case ◽  
Clinical Case Study

scholarly journals Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Katsuya Mitamura ◽  
Takashi Norikane ◽  
Yuka Yamamoto ◽  
Kengo Fujimoto ◽  
Yasukage Takami ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Fdg Pet ◽  
Tumor Volume ◽  
Standardized Uptake Value ◽  
Complete Response ◽  
Neck Squamous Cell Carcinoma ◽  
Pet Ct

Abstract Purpose We investigated the potential of interim 4′-[methyl-11C]thiothymidine ([11C]4DST) PET for predicting the chemoradiotherapeutic response for head and neck squamous cell carcinoma (HNSCC), in comparison with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET. Methods A total of 32 patients with HNSCC who underwent both [11C]4DST and [18F]FDG PET/CT before therapy (baseline) and at approximately 40 Gy point during chemoradiotherapy (interim) were available for a retrospective analysis of prospectively collected data. The baseline was treatment-naïve PET/CT scan as part of staging. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV) from [18F]FDG PET or proliferative tumor volume (PTV) from [11C]4DST PET, and total lesion glycolysis (TLG) from [18F]FDG PET or total lesion proliferation (TLP) from [11C]4DST PET were measured. MTV or PTV was defined as the volume with an SUVmax greater than 2.5. The differences in SUVmax (ΔSUVmax), MTV (ΔMTV) or PTV (ΔPTV) and TLG (ΔTLG) or TLP (ΔTLP) from baseline to interim PET scans were calculated. Patients without or with evidence of residual or recurrent disease at 3 months after completion of chemoradiotherapy were classified as showing a complete response (CR) and non-CR, respectively. Results All patients showed increased uptake in primary tumor on baseline [11C]4DST and [18F]FDG PET studies. All patients showed increased uptake on interim [18F]FDG PET, whereas 18 patients showed no increased uptake on interim [11C]4DST PET. After chemoradiotherapy, 25 patients were found to be in CR group and 7 to be in non-CR group. [11C]4DST ΔSUVmax, ΔPTV, and ΔTLP for CR group showed significantly greater reductions than the corresponding values for non-CR group (P = 0.044, < 0.001, < 0.001, respectively). However, there were no significant differences in [18F]FDG ΔSUVmax, ΔMTV, or ΔTLG between CR group and non-CR group. [11C]4DST ΔMTV of -90 was the best cutoff value for the early identification of patients with non-CR. Conclusion These preliminary results suggest that interim [11C]4DST PET might be useful for predicting the chemoradiotherapeutic response in patients with HNSCC, in comparison with [18F]FDG PET.

Referred Vaginal Pain: Cause of Hypersensitivity and Performance Problems in Mares? A Clinical Case Study

2007 ◽  
Vol 27 (1) ◽  
pp. 32-36 ◽  
Author(s):  
M. Christoffersen ◽  
H. Lehn-Jensen ◽  
I.B. Bøgh
Keyword(s):  
Clinical Case ◽  
Clinical Case Study ◽  
Vaginal Pain ◽  
Performance Problems ◽  
And Performance

Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature

2016 ◽  
Vol 28 (5) ◽  
pp. 432-434 ◽  
Author(s):  
Beatrice Detti ◽  
Giulio Francolini ◽  
Carlotta Becherini ◽  
Emanuela Olmetto ◽  
Irene Giacomelli ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Clinical Case ◽  
Complete Response ◽  
Review Of The Literature
Sign in / Sign up

Export Citation Format

Share Document